U.S. Water Utilities Stock News

In early April 2026, IDEXX Laboratories launched its IDEXX Cancer Dx Panel for early lymphoma detection in at-risk dogs across UK veterinary practices, offering blood-based screening that integrates into existing wellness and diagnostic workflows with results delivered in 3–5 business days. This launch not only broadens IDEXX’s preventative care portfolio but also taps into strong pet-owner interest in cancer screening and builds on early adoption of the test by thousands of clinics in North...

Morgan Stanley’s upgrade of Lemonade (LMND), tied to its new Tesla auto insurance partnership, has pulled fresh attention to the insurer’s AI focus as investors reassess the stock after a volatile few months. See our latest analysis for Lemonade. The Tesla tie up and South Carolina renters launch come after a sharp rebound, with a 21% share price gain in March and a 1 year total shareholder return of 118.21% following earlier weakness. Momentum has picked up despite a 19.08% year to date...

Event driven snapshot for PBF Energy (PBF) PBF Energy (PBF) shares recently closed at US$45.39 after a 1-day return of a 1.52% decline and a 7-day return of an 11.40% decline, putting recent volatility front and center for investors watching the refiner. See our latest analysis for PBF Energy. While the recent 7 day share price return of an 11.40% decline signals fading short term momentum, the 90 day share price return of 53.86% and 1 year total shareholder return of 214.74% still point...

Understanding Penguin Solutions after its recent rebrand Penguin Solutions (PENG) recently changed its name from SMART Global Holdings, a shift that brings its high performance computing, AI infrastructure, memory, and LED businesses together under a single, clearer identity for investors to evaluate. See our latest analysis for Penguin Solutions. The recent rebrand has arrived alongside sharp near term share price momentum, with a 1 day share price return of 13.37% and 7 day share price...

Live Oak Bancshares (LOB) has drawn investor attention after reporting 16.8% year on year revenue growth that topped expectations, while missing EPS and tangible book value estimates. This mix coincided with a sharp share price drop. See our latest analysis for Live Oak Bancshares. Beyond the immediate earnings reaction, Live Oak Bancshares’ share price at US$33.39 sits below its recent highs. It has a 7 day share price return of 4.05%, a 90 day share price return decline of 6.63%, while the...

In recent weeks, Modine Manufacturing reported earnings that exceeded market expectations, accompanied by heightened interest from large institutional investors and sustained analyst optimism around its thermal solutions business. Beyond financial results, the company’s pivot toward AI-focused liquid cooling and its participation in the U.S. Department of Energy’s Better Plants program highlight how its growth ambitions are increasingly tied to energy efficiency and data center...

In March 2026, Clarivate Plc released the Clarivate AI50, a data-driven benchmark ranking 50 leading organizations in high-impact artificial intelligence inventions, built on its Derwent World Patents Index and Strength Index analytics. The report highlights how AI innovation is clustering in a few countries and sectors, with government and academic institutions playing an outsized role in advancing foundational research and cross-border collaboration. We’ll now examine how this new AI50...

In recent weeks, ADMA Biologics has come under scrutiny as multiple law firms launched securities fraud investigations following a short-seller report alleging inflated revenue, channel stuffing, and undisclosed related-party sales tied to its plasma-derived therapies. This wave of legal and reputational pressure raises pointed questions about the reliability of ADMA’s reported growth and the sustainability of its current business practices. We’ll now examine how these channel-stuffing and...

In early April 2026, Superpower announced a partnership with GRAIL, Inc. to offer the Galleri multi-cancer early detection blood test through its preventative health platform, giving members nationwide access to screening for signals across more than 50 cancer types with integrated clinical support. By embedding Galleri into a broader biomarker and AI-driven care model for both individuals and employer populations, the collaboration positions GRAIL’s test as part of a comprehensive early...

Why Yum China’s 2026 proxy filing matters for shareholders Yum China Holdings (YUMC) has put its 2026 annual meeting in motion with a preliminary proxy filing that sets up shareholder votes on the board, executive pay, auditor choice, share issuance, and potential buybacks. See our latest analysis for Yum China Holdings. Against this proxy backdrop, Yum China’s recent share price performance has been mixed, with a 5.1% decline over the past month but a 4.99% 3 month share price return and a...

In recent days, LegalZoom.com’s AI legal assistant was registered through GoDaddy’s Agent Name Service open standard, while Barclays downgraded the company and S&P announced its addition to key mid- and small-cap indices, highlighting both innovation efforts and reassessed growth expectations. The combination of AI-focused partnerships, a US$100,000,000 share repurchase program, and index inclusion is testing how durable LegalZoom’s business model and addressable market assumptions really...

Recent performance snapshot Silgan Holdings (SLGN) has drawn attention after a mixed stretch in the stock, with a 3.7% gain over the past week, an 11.1% decline over the month, and a 15.9% drop over the past year. See our latest analysis for Silgan Holdings. With the share price at $39.48, Silgan’s recent 7 day share price return of 3.68% contrasts with a 30 day share price return decline of 11.10% and a 1 year total shareholder return decline of 15.95%. This pattern suggests momentum has...

West Pharmaceutical Services recently opened a 165,000-square-foot expansion at its Damastown, Dublin site, boosting contract services with advanced automation and commercial-scale drug-handling capabilities for high-volume injectable therapies such as diabetes and obesity treatments. This investment deepens the reach of the West Vantage contract services platform, positioning West as a more integrated, single-source partner for pharmaceutical and biotechnology companies seeking to bring...

ZenaTech, Inc. recently advanced its defense and enterprise software ambitions by developing an AI-driven counter-UAS ecosystem, expanding drone manufacturing into Ukraine, and growing its Othership workspace management platform through a new partnership with Achieve Engagement. This combination of defense-focused hardware and AI with a separate push into workplace SaaS highlights ZenaTech’s unusually diversified approach across military and commercial markets. With recent share price gains,...

F5 (FFIV) is drawing fresh attention after two developments: an alliance with Forcepoint to secure AI systems across their lifecycle, and an upgraded earnings outlook from analysts ahead of upcoming quarterly results. See our latest analysis for F5. The recent 2.6% 1 day share price return to US$303.35 sits on top of a 30 day share price return of 6% and a 90 day gain of 11.5%. The 1 year total shareholder return of 26.8% and 3 year total shareholder return of around 2x suggest momentum has...

Ecovyst (ECVT) set fresh expectations for 2026, guiding full-year revenue to a range of $860 million to $940 million, tied to refinery utilization, mining demand, and regeneration services expansion. See our latest analysis for Ecovyst. The 18.2% 1 month share price return and 31.6% year to date share price return to $13.04 suggest building momentum, while the 134.1% 1 year total shareholder return highlights how recent expectations have reshaped sentiment around Ecovyst. If Ecovyst’s move...

COPT Defense Properties recently highlighted its dividend profile, with the annualized payout up 4.9% from last year and a current yield of 4.18%, alongside expectations for fiscal 2026 earnings of US$2.77 per share. This combination of steady dividend growth and projected earnings expansion underscores the REIT’s appeal for investors seeking income alongside operational stability in defense-focused real estate. Next, we’ll examine how this stronger dividend trajectory and earnings outlook...

Why Autohome’s Latest Insider Move And Earnings Are Getting Attention Autohome (NYSE:ATHM) is back in focus after Chief Financial Officer Yan Zeng sold 2,704 shares, shortly after the company released a mixed Q4 report that paired strong full-year growth with softer quarterly profits. See our latest analysis for Autohome. The share price has been under pressure for some time, with a 30 day share price return of 8.97%, a year to date share price decline of 23.46%, and a 5 year total...

Wells Fargo’s decision to initiate coverage on CACI International (CACI) with an Overweight rating has pushed the stock into focus as investors weigh this fresh analyst attention against the company’s recent operational track record. See our latest analysis for CACI International. Recent trading reflects mixed momentum, with a 2.6% 1 day share price return and a 7.1% year to date share price return sitting alongside a 49.1% 1 year total shareholder return and a 92.7% 3 year total shareholder...

In recent months, Waters Corporation outlined its post-acquisition plans for BD Diagnostic Solutions at a major healthcare conference, while Goldman Sachs resumed coverage with a positive stance despite earlier Biosciences and Diagnostic division challenges. This combination of clearer integration priorities and external endorsement has refocused attention on how Waters might balance acquisition-driven expansion with efficiency and profitability concerns. We’ll now examine how Waters’...

In early April 2026, BMO Capital analyst Daniel DiCicco initiated coverage of AMETEK with an Outperform rating, shortly after the company completed its acquisition of ophthalmic diagnostics specialist LKC Technologies for integration into its Electronic Instruments Group. This combination of fresh analyst attention and expansion into specialized medical diagnostics adds a new layer of diversification to AMETEK’s instruments portfolio. Next, we’ll examine how BMO’s optimistic coverage,...

Broadridge Financial Solutions (BR) is back in focus after Q2 2026 earnings topped analyst expectations, the company raised its recurring revenue outlook, and CEO Timothy C. Gokey added to his stake in the stock. See our latest analysis for Broadridge Financial Solutions. The Q2 beat and raised recurring revenue outlook came after a weak recent share price run, with a 30 day share price return of 18.26% and year to date share price return of 27.01%, even though the 3 year total shareholder...

Solventum Corporation recently marked the opening of its US$200 million Innovation Hub in Eagan, Minnesota, while Chief Accounting Officer Mary Wilcox informed the company on March 20, 2026 of her intention to retire once a successor is appointed. The new facility, supported by about US$13 million in state business development funding and housing more than 1,800 employees, underscores Solventum’s emphasis on research, development and long-term healthcare innovation capacity. Now we’ll...

Contract win puts fresh focus on US Foods Holding (USFD) US Foods Holding (USFD) just secured a maximum firm-fixed-price contract worth up to US$137.11 million to supply full-line food and beverage items to U.S. military services in Arizona through early 2027. The 322 day bridge agreement with the Defense Logistics Agency Troop Support adds government volume alongside the company’s broad commercial customer base and gives investors a defined revenue stream tied to Army, Navy, Air Force, and...